Cagla Bahar Bulbul

Dr. Cagla Bahar Bulbul

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
CBCagla Bahar Bulbul
Cagla Bahar Bulbul
BYbetül yakıştıran
betül yakıştıran
Objectives: This study aimed to evaluate whether first-trimester metabolic markers—including the triglyceride-glucose (TyG) index and lipid-related ratios (TG/HDL-c, LDL-c/HDL-c, and TyG/BMI)—could predict the development of late-onset preeclampsia, and to assess their associations with birthweight and birth length. Methods: A retrospective cohort study was conducted on 306 pregnant women (153 with late-onset PE and 153 normotensive controls). Demographic and clinical data, including maternal lipid profiles, TyG index, and other biochemical markers, were collected during the first trimester. Statistical analyses, including Mann–Whitney, two-sided t-tests, and receiver operating characteristic curves (ROC), were performed to assess the predictive value of the TyG index and other ratios in predicting late-onset PE. Results: Significant differences between the PE and control groups were observed in delivery method, birthweight, and birthlength (p < 0.05). ROC analysis revealed that the TyG index had an area under the curve (AUC) of 0.79, with a sensitivity of 69.3% and specificity of 75.8%. The TyG index was inversely associated with birthweight (ρ = −0.288) and gestational age at delivery (ρ = −0.218), while positively correlating with systolic blood pressure (ρ = 0.441). Conclusions: The TyG index, along with TG/HDL and LDL-c/HDL ratios, demonstrated predictive value for late-onset PE. These findings suggest that elevated TyG index levels may contribute to adverse pregnancy outcomes such as intrauterine growth restriction and preterm delivery. First-trimester lipid profiles and the TyG index may serve as valuable markers for early prediction of late-onset PE.

15 July 2025 in Archives of Medical Research
Verified
Journal Article
Closed access
CBCagla Bahar Bulbul
Cagla Bahar Bulbul
GTGulay Turan
Gulay Turan
CUCeyda Sancakli Usta
Ceyda Sancakli Usta
OBOzgur Bulmus
Ozgur Bulmus
AUAkin Usta
Akin Usta

4 August 2026 in Physiology & Behavior
Verified
Journal Article
Closed access
AKAslı Karakılıç
Aslı Karakılıç
CBCagla Bahar Bulbul
Cagla Bahar Bulbul
MAMerve Akis
Merve Akis
EÖEmrah Özcan
Emrah Özcan
SYSimge Tezel Yozgat
Simge Tezel Yozgat
BŞBurak Şafak
Burak Şafak

4 September 2026 in Journal of the Turkish-German Gynecological Association
Verified
Journal Article
Open access
PDF file
CBCagla Bahar Bulbul
Cagla Bahar Bulbul
VKVolkan Karataş
Volkan Karataş
SYSimge Tezel Yozgat
Simge Tezel Yozgat
Maternal and neonatal outcomes following cesarean myomectomy: a comparison between fibroid-associated and fibroid-free cesarean deliveries - Journal of the Turkish-German Gynecological Association


19 February 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
CBCagla Bahar Bulbul
Cagla Bahar Bulbul
BYBetul Yakistiran
Betul Yakistiran
Objective: This study aimed to evaluate the predictive value of second-trimester hemoglobin levels, the hemoglobin–albumin–lymphocyte–platelet (HALP) index, the fibrinogen-to-albumin ratio (FAR), and selected coagulation and platelet activation markers for the development of preeclampsia. Methods: This retrospective cohort study included 262 pregnant women, comprising 131 women who developed preeclampsia and 131 normotensive controls, followed at a tertiary referral center between 2022 and 2023. Maternal demographic, clinical, and laboratory data were obtained from routine second-trimester (14–28 weeks) antenatal assessments. HALP and FAR were calculated using standardized formulas. Group comparisons were performed using appropriate parametric or nonparametric tests. Discriminative performance was assessed using receiver operating characteristic (ROC) curve analysis with bootstrap resampling. Univariate and multivariable logistic regression models were constructed to evaluate independent associations, and combined biomarker models were compared using DeLong’s test. Results: Women with preeclampsia demonstrated significantly lower hemoglobin, hematocrit, platelet count, and albumin levels, alongside higher fibrinogen, D-dimer, LDH, CRP, and platelet activation indices (MPV, PDW, and P-LCR) (all p < 0.05). Both HALP and FAR were significantly higher in the preeclampsia group; however, FAR exhibited superior discriminatory ability (AUC 0.682; 95% CI 0.618–0.751) compared with HALP (AUC 0.619; 95% CI 0.551–0.680). In multivariable analysis, FAR remained a strong independent predictor of preeclampsia (adjusted OR 1.263; 95% CI 1.167–1.368), whereas HALP showed a weaker association. Among combined models, FAR plus platelet distribution width (PDW) provided the highest discrimination (AUC 0.820), significantly outperforming FAR alone (DeLong p = 0.030). Conclusion: While the FAR + PDW model demonstrated improved discriminatory performance, these findings should be interpreted as preliminary. Prospective multicenter studies and external validation are necessary before such biomarkers can be considered for routine clinical use.